Geode Capital Management
COCP icon

Geode Capital Management’s Cocrystal Pharma COCP Stock Holding History

Geode Capital Management’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$143K Buy
124,446
+48,238
+63% +$51.6K ﹤0.01% 3965
2026
Q2 		$80K Sell
76,208
-14,023
-16% -$17.3K ﹤0.01% 4144
2026
Q1 		$91.1K Buy
90,231
+7,732
+9% +$7.98K ﹤0.01% 4159
2025
Q4 		$80.8K Buy
82,499
+8,570
+12% +$9.07K ﹤0.01% 4145
2025
Q3 		$92.4K Buy
73,929
+829
+1% +$1.28K ﹤0.01% 4152
2025
Q2 		$109K Sell
73,100
-19
-0% -$28 ﹤0.01% 4036
2025
Q1 		$104K Buy
73,119
+4,229
+6% +$7.89K ﹤0.01% 4022
2024
Q4 		$139K Buy
68,890
+2,630
+4% +$5.26K ﹤0.01% 4004
2024
Q3 		$117K Buy
66,260
+1,428
+2% +$2.78K ﹤0.01% 4060
2024
Q2 		$151K Buy
64,832
+4,400
+7% +$8.58K ﹤0.01% 4007
2024
Q1 		$86.4K Hold
60,432
– – ﹤0.01% 4205
2023
Q4 		$103K Hold
60,432
– – ﹤0.01% 4182
2023
Q3 		$113K Sell
60,432
-9,102
-13% -$22.8K ﹤0.01% 4206
2023
Q2 		$166K Hold
69,534
– – ﹤0.01% 4123
2023
Q1 		$138K Hold
69,534
– – ﹤0.01% 4214
2022
Q4 		$134K Buy
69,534
+2,084
+3% +$5.34K ﹤0.01% 4284
2022
Q3 		$235K Hold
67,450
– – ﹤0.01% 4112
2022
Q2 		$331K Buy
67,450
+733
+1% +$3.9K ﹤0.01% 3977
2022
Q1 		$440K Hold
66,717
– – ﹤0.01% 3997
2021
Q4 		$520K Hold
66,717
– – ﹤0.01% 4022
2021
Q3 		$840K Buy
66,717
+20,189
+43% +$267K ﹤0.01% 3775
2021
Q2 		$697K Buy
46,528
+17,704
+61% +$269K ﹤0.01% 3781
2021
Q1 		$480K Buy
28,824
+1,181
+4% +$24K ﹤0.01% 3832
2020
Q4 		$451K Buy
27,643
+6,360
+30% +$88.3K ﹤0.01% 3622
2020
Q3 		$237K Sell
21,283
-696
-3% -$12.7K ﹤0.01% 3669
2020
Q2 		$400K Buy
21,979
+18,489
+530% +$227K ﹤0.01% 3444
2020
Q1 		$29K Buy
+3,490
New +$32.9K ﹤0.01% 4004

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Clean Yield Group
Clean Yield Group Norwich, Vermont $412M AUM 20.54% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
NVWM LLC
NVWM LLC Yardley, Pennsylvania $533M AUM 27.53% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Geode Capital Management's COCP Position: Q3 2026 in Review

Geode Capital Management increased its Cocrystal Pharma (COCP) stake by 63% in Q3 2026, buying an estimated $51.6K and bringing the position to 124,446 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #3965.

Geode Capital Management first reported a position in COCP in Q1 2020 and has held it in 27 quarters since. The position peaked at $840K in Q3 2021. 14 funds tracked by Wall St. Rank hold COCP as of Q3 2026.

  • Geode Capital Management held 124,446 shares of Cocrystal Pharma worth $143K as of Q3 2026.
  • Geode Capital Management bought 48,238 Cocrystal Pharma shares in Q3 2026, an estimated $51.6K.
  • Cocrystal Pharma made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3965 holding.
  • Geode Capital Management first reported a position in Cocrystal Pharma in Q1 2020 and has held it in 27 quarters since.
  • Geode Capital Management's Cocrystal Pharma position peaked at $840K in Q3 2021.
  • 14 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.